Antibody Response After SARS-CoV-2 Infection and Implications for Immunity : A Rapid Living Review.

ABSTRACT:

Background

The clinical significance of the antibody response after SARS-CoV-2 infection remains unclear.

Purpose

To synthesize evidence on the prevalence, levels, and durability of detectable antibodies after SARS-CoV-2 infection and whether antibodies to SARS-CoV-2 confer natural immunity.

Data sources

MEDLINE (Ovid), Embase, CINAHL, Cochrane Central Register of Controlled Trials, ClinicalTrials.gov, World Health Organization global literature database, and Covid19reviews.org from 1 January through 15 December 2020, limited to peer-reviewed publications available in English.

Study selection

Primary studies characterizing the prevalence, levels, and duration of antibodies in adults with SARS-CoV-2 infection confirmed by reverse transcriptase polymerase chain r

SUBMITTER: Arkhipova-Jenkins I 

PROVIDER: S-EPMC8025942 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature